Venus Concept Inc. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16th

Rhea-AI Summary

Venus Concept, a leader in medical aesthetic technology, announced its participation in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference. The management will engage in a virtual fireside chat on February 16, 2022, at 11:00 a.m. ET. The webcast will be accessible to BTIG clients attending the event. Venus Concept offers a diverse product range, including aesthetic devices and hair restoration technologies, and operates in over 60 countries. Notable backers include EW Healthcare Partners and HealthQuest Capital.

TORONTO, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference.

Management will participate in a virtual fireside chat at the conference on Wednesday, February 16th at 11:00 a.m. Eastern Time. A webcast of the fireside chat will be available to BTIG clients attending the conference via the conference website. To listen to the live event, please contact your BTIG representative.

About Venus Concept

Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reach in over 60 countries and 18 direct markets. Venus Concept focuses its product sales strategy on a subscription-based business model in North America and in its well-established direct global markets. Venus Concept’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Freedom, Venus Viva, Venus Glow, Venus Bliss, Venus BlissMAX, Venus Epileve and Venus Viva MD. Venus Concept’s hair restoration systems include NeoGraft®, an automated hair restoration system that facilitates the harvesting of follicles during a FUE process and the ARTAS® and ARTAS iX® Robotic Hair Restoration systems, which harvest follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, and Aperture Venture Partners.

FAQ

When is Venus Concept's presentation at the BTIG Conference?

Venus Concept will participate in the BTIG Virtual MedTech Conference on February 16, 2022, at 11:00 a.m. ET.

How can I listen to the Venus Concept fireside chat?

To listen to the Venus Concept fireside chat, BTIG clients can access the webcast via the conference website.

What products does Venus Concept offer?

Venus Concept offers a variety of aesthetic devices and hair restoration technologies, including Venus Versa and NeoGraft.

What is the stock symbol for Venus Concept?

The stock symbol for Venus Concept is VERO.

Who are the investors backing Venus Concept?

Venus Concept is backed by investors like EW Healthcare Partners and HealthQuest Capital.